328 related articles for article (PubMed ID: 9062347)
1. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms.
Zhang Y; McCluskey K; Fujii K; Wahl LM
J Immunol; 1998 Sep; 161(6):3071-6. PubMed ID: 9743373
[TBL] [Abstract][Full Text] [Related]
3. Suppression of prostaglandin H synthase-2 induction in human monocytes by in vitro or in vivo administration of interleukin 4.
Mertz PM; Corcoran ML; McCluskey KM; Zhang Y; Wong HL; Lotze MT; DeWitt DL; Wahl SM; Wahl LM
Cell Immunol; 1996 Nov; 173(2):252-60. PubMed ID: 8912884
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human monocyte matrix metalloproteinases by SPARC.
Shankavaram UT; DeWitt DL; Funk SE; Sage EH; Wahl LM
J Cell Physiol; 1997 Dec; 173(3):327-34. PubMed ID: 9369945
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production.
Mertz PM; DeWitt DL; Stetler-Stevenson WG; Wahl LM
J Biol Chem; 1994 Aug; 269(33):21322-9. PubMed ID: 8063757
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
Vaday GG; Schor H; Rahat MA; Lahat N; Lider O
J Leukoc Biol; 2001 Apr; 69(4):613-21. PubMed ID: 11310848
[TBL] [Abstract][Full Text] [Related]
7. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
8. Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes.
Corcoran ML; Stetler-Stevenson WG; DeWitt DL; Wahl LM
Arch Biochem Biophys; 1994 May; 310(2):481-8. PubMed ID: 8179336
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis.
Jovanovic DV; Martel-Pelletier J; Di Battista JA; Mineau F; Jolicoeur FC; Benderdour M; Pelletier JP
Arthritis Rheum; 2000 May; 43(5):1134-44. PubMed ID: 10817568
[TBL] [Abstract][Full Text] [Related]
10. Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin-1alpha and tumor necrosis factor-alpha through a prostaglandin-dependent pathway.
Lin SK; Wang CC; Huang S; Lee JJ; Chiang CP; Lan WH; Hong CY
J Endod; 2001 Mar; 27(3):185-9. PubMed ID: 11487149
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.
Gipson TS; Bless NM; Shanley TP; Crouch LD; Bleavins MR; Younkin EM; Sarma V; Gibbs DF; Tefera W; McConnell PC; Mueller WT; Johnson KJ; Ward PA
J Immunol; 1999 Mar; 162(6):3653-62. PubMed ID: 10092827
[TBL] [Abstract][Full Text] [Related]
13. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
Jovanovic DV; Di Battista JA; Martel-Pelletier J; Reboul P; He Y; Jolicoeur FC; Pelletier JP
J Rheumatol; 2001 Apr; 28(4):712-8. PubMed ID: 11327240
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes.
Corcoran ML; Stetler-Stevenson WG; Brown PD; Wahl LM
J Biol Chem; 1992 Jan; 267(1):515-9. PubMed ID: 1309751
[TBL] [Abstract][Full Text] [Related]
16. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM
Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216
[TBL] [Abstract][Full Text] [Related]
17. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
18. Regulation of monocyte/macrophage metalloproteinase production by cytokines.
Wahl LM; Corcoran ML
J Periodontol; 1993 May; 64(5 Suppl):467-73. PubMed ID: 8391076
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture.
Kim MP; Zhou M; Wahl LM
J Leukoc Biol; 2005 Jul; 78(1):195-201. PubMed ID: 15817699
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes.
Scherle PA; Jones EA; Favata MF; Daulerio AJ; Covington MB; Nurnberg SA; Magolda RL; Trzaskos JM
J Immunol; 1998 Nov; 161(10):5681-6. PubMed ID: 9820549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
